MCKESSON SPECIALTY HEALTH PHARMACEUTICAL & BIOTECH SOLUTIONS LLC

Mckesson Specialty Health Pharmaceutical & Biotech Solutions LLC specializes in the manufacturing of specialized pharmaceutical preparations and the application of real-world data analytics to advance clinical understanding of rare diseases. Their technical expertise spans GMP-compliant drug manufacturing processes, including capsule formulation and active pharmaceutical ingredient handling, as well as the design and execution of observational research studies leveraging electronic health records and claims data to characterize disease progression in community oncology settings. The company differentiates itself through its ability to bridge pharmaceutical production with evidence generation, supporting regulatory and clinical decision-making with actionable insights derived from real-world evidence. Their work in rare cancer natural history studies demonstrates a sophisticated command of epidemiological methods, data harmonization, and outcomes research frameworks. The contractor has delivered services to the Department of Veterans Affairs and the Department of Health and Human Services, focusing on the supply of standardized pharmaceutical products and the conduct of health services research aimed at improving patient outcomes in underserved populations. These engagements reflect a consistent alignment with federal priorities in oncology care, drug accessibility, and data-driven policy development. Their primary industry focus lies in pharmaceutical preparation manufacturing and social science research, positioning them at the intersection of biopharmaceutical production and health outcomes analysis. This dual specialization enables them to support both the supply chain and evidence-generation needs of public health programs. As a 2L entity based in Irving, Texas, the company operates as a mid-tier contractor with no federal certifications on record. Their geographic footprint is centered in Texas, with a targeted market presence in federal health and pharmaceutical procurement channels, serving agencies focused on veteran care and public health innovation.